Dietary vitamin K intake and stability of anticoagulation with coumarins; evidence derived from a clinical trial;El consumo de vitamina K y la estabilidad de la anticoagulación con cumarínicos; evidencia derivada de ensayo clínico

Nutricion Hospitalaria

Volumn 27, Issue 6, 2012, Pages 1987-1992

  Zuchinali, P ^a   Souza, G C ^b   de Assis, M C S ^c   Rabelo, E R ^b,c   Paim Rohde, Luis Eduardo ^a,b,c  

^a Cardiology and Cardiovascular Sciences   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anticoagulants; Coumarin; Food consumption; Vitamin K; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; VITAMIN K GROUP;

AGED; CHRONIC DISEASE; CONTROLLED STUDY; DIET; FEMALE; FOOD DRUG INTERACTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTICOAGULANTS; CHRONIC DISEASE; COUMARINS; DIET; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; VITAMIN K;

EID: 84874722381     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.6.6068     Document Type: Article

References (22)

1. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest 2001; 119: 8S-21S.
2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S-198S.
3. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson DR, Poller L, Jacobson A, Deykin D, Matchar DL. Managing Oral Anticoagu-lant Therapy. Chest 2001; 119: 22S-38S.
4. Monagle P, Chalmers E, Chan A, deVeber G, Kirkham F, Massicotte P, Michelson AD. Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 887S-968S.
5. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation. JAMA 1998; 279: 657-662.
6. Cannegieter SC, Rosendaal FR, Wintzen AR, Van Der Meer FJM, Vandenbroucke JP, Briët R. Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves. N Engl J Med 1995; 333: 11-17.
7. Penning-van Beest FJA, Geleijnse JM, van Meegen E, Vermeer C, Rosendaal FR, Stricker BHC. Lifestyle and diet as risk factors for overanticoagulation. J Clin Epidemiol 2002; 55: 411-417.
8. Rombouts EK, Rosendaal FR, van der Meer FJL. Subtherapeutic oral anticoagulant therapy: Frequency and risk factors. Thromb Haemost 2009; 101: 552-556.
9. Ávila CW, Aliti GB, Feijó MFK, Rabelo ER. Pharmacological Adherence to Oral Anticoagulant and Factors that Influence the International Normalized Ratio Stability. Rev Latino-Am Enfermagem 2011; 19: 18-25.
10. Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 2004; 116: 651-656.
11. Assis MC, Rabelo ER, Ávila CW, Polanczyk CA, Rohde LE. Improved Oral Anticoagullation After a Dietary Vitamin KGuided Strategy-A Randomized Controlled Trial. Circulation 2009; 120: 1115-1122.
12. Couris R, Tatronis G, McCloskey W, Oertel L, Dallal G, Dwyer J, Blumberg JD. Dietary Vitamin K variability affects international normalized ratio (INR) coagulation indices. Int J Vitam Nutr Res 2006; 76: 65-74.
13. Rombouts EK, Rosendaal FR, van der Meer FJ. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol 2010; 149: 598-605.
14. Sconce EA, Khan T, Mason J, Noble F, Wynne H, Kamali F. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-875.
15. Rombouts EK, Rosendaal FR, van der Meer FJM. Daily vitamin K supplementation improves anticoagulant Stability. Journal of Thrombosis and Haemostasis 2007; 5: 2043-2048.
16. Sconce E, Avery P, Wynne H, Kamali F. (Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-2423.
17. Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P, Kesteven P, Kamali F. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Brit J Haematol 2004; 124: 348-354.
18. Kurnik D, Loebstein R, Rabinovitz H, Austerweil N, Halkin H, Almog S. Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial. Thromb Haemost 2004; 92: 1018-24.
19. Kim KH, Choi WS, Lee JH, Lee H, Yang DH, Chae SC. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin. Thromb Haemost 2010; 104: 755-9.
20. Gebuis EPA, Rosendaal FR, van Meegen E, van der Meer FJM. Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin antagonists: a dose-finding study. Haematologica 2011; 96: 583-589.
21. Couris RR, Tataronis GC, Dallal GE, Blumberg JB, Dwyer JT. Assessment of healthcare professionals' knowledge about warfarin vitaminK drug-nutrient interactions. J Am Coll Nutr 2000; 19: 439-445.
22. Rohde LE, Assis MC, Rabelo ER. Dietary vitamin K intake and anticoagulation in elderly patients. Curr Opin Clin Nutr Metab Care 2007; 10: 1-5.